Medindia

X

Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement

Wednesday, November 25, 2009 General News J E 4
Advertisement

COMPANY CONTACT:

INVESTOR CONTACTS:

Endologix, Inc.

The Ruth Group

John McDermott, CEO

Nick Laudico (646) 536-7030

(949) 595-7200

Zack Kubow (646) 536-7020

www.endologix.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Sky Foundation, Inc. Raises More Than $100,000 to ...
S
DynaVox EyeMax Featured in Good Morning America Se...